Dorzolamide Hydrochloride-Timolol Maleate Articles
Xalacom outperforms Cosopt in glaucoma
13 May 2002
Aggrastat Backed For Unstable Angina
14 April 1998
Analysts Assess Outlook For US Drug Majors
8 January 1998
...Merck Confident It Can Hold Growth Rates
9 December 1997
Showing 1-5 of 5 articles
- 1
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Italy's pharma market slump set to continue, warns GlobalData
